Innovation Pharmaceuticals Inc.
OTC: IPIX0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Other OTC
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Leo Ehrlich
- Employees
- 4
- Headquarters
- Wakefield, United States
- IPO year
- 2007
- Market cap
- $155.5K
- Website
- https://www.ipharminc.com
Loading IPIX…
Loading profile data…Frequently asked questions about IPIX
What does Innovation Pharmaceuticals Inc. (IPIX) do?
Innovation Pharmaceuticals Inc. is a clinical-stage biopharmaceutical company dedicated to the development of small molecule therapies. Its pipeline targets a range of medical areas, including inflammatory diseases, cancer, dermatology, and infectious conditions. The company's lead drug candidate, Brilacidin, is currently in development for trea...
Where does IPIX trade?
Innovation Pharmaceuticals Inc. (IPIX) trades on the Other OTC.
What sector is IPIX in?
Innovation Pharmaceuticals Inc. (IPIX) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of Innovation Pharmaceuticals Inc.?
Leo Ehrlich is the chief executive officer of Innovation Pharmaceuticals Inc. (IPIX).
Where is Innovation Pharmaceuticals Inc. headquartered?
Innovation Pharmaceuticals Inc. is headquartered in United States.
Does IPIX pay a dividend?
Innovation Pharmaceuticals Inc. (IPIX) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did IPIX go public?
Innovation Pharmaceuticals Inc. (IPIX) completed its initial public offering in 2007.